Biotechnology major Biocon's scrip today rose by 5 per cent after the company reported 47 per cent rise in consolidated net profit for the June quarter.
The stock gained 4.96 per cent to close at Rs 586.85 on BSE. Intra-day, it had jumped 9.81 per cent to Rs 614.
On NSE, the stock moved up by 4.75 per cent to end at Rs 584.80.
On the equity volume front, 10.25 lakh shares of the company were traded on BSE and over one crore shares changed hands at NSE during the day.
Biocon yesterday reported 47 per cent rise in consolidated net profit to Rs 120 crore for the first quarter of the current fiscal, 2018-19, on robust performance across segments.
The company had posted a net profit of Rs 81 crore for the April-June of last fiscal.
Consolidated total revenue of the company stood at Rs 1,193 crore for the quarter under consideration. It was Rs 988 crore for the same period a year ago.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)